| |
| |
|
| Insider
Information: |
Martin Rod D |
| Relationship: |
Director |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
202,089 |
|
|
Indirect Shares
|
2,776,186 |
|
|
| Direct
Value |
$674,977 |
|
|
|
Indirect Value
|
$9,272,461 |
|
|
| Total
Shares |
2,978,275 |
|
|
| Total
Value |
$9,947,439 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
Director |
2015-04-08 |
202,089 |
2015-04-08 |
2,776,186 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
26,395 |
202,089 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,784 |
176,606 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-05-13 |
4 |
OE |
$1.80 |
$150,001 |
D/D |
83,334 |
174,822 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-01-27 |
4 |
OE |
$3.00 |
$1,500,000 |
I/I |
500,000 |
2,776,186 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-01-13 |
4 |
S |
$14.00 |
$812,203 |
I/I |
(58,000) |
9,357,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-01-10 |
4 |
S |
$16.00 |
$672,118 |
I/I |
(42,000) |
9,415,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2013-11-01 |
4 |
OE |
$3.00 |
$600,000 |
I/I |
200,000 |
9,457,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2013-10-16 |
4 |
OE |
$3.00 |
$900,000 |
I/I |
300,000 |
9,257,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2013-10-08 |
4 |
S |
$12.36 |
$148,270 |
I/I |
(12,000) |
8,957,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2013-10-07 |
4 |
S |
$11.79 |
$1,179,160 |
I/I |
(100,000) |
8,969,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2012-05-25 |
4 |
B |
$2.44 |
$12,200 |
D/D |
5,000 |
91,488 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2011-09-30 |
4 |
A |
$0.92 |
$190,227 |
I/I |
206,724 |
9,069,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2011-09-30 |
4 |
OE |
$0.50 |
$1,205,000 |
I/I |
2,410,000 |
8,862,698 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2011-06-30 |
4 |
OE |
$1.22 |
$4,379,800 |
I/I |
3,590,000 |
6,452,698 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2011-06-30 |
4 |
A |
$1.22 |
$464,180 |
I/I |
380,475 |
2,862,698 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2011-03-31 |
4 |
A |
$1.04 |
$395,694 |
I/I |
380,475 |
2,482,223 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-12-31 |
5 |
A |
$0.90 |
$342,428 |
I/I |
380,475 |
2,101,748 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-09-30 |
5 |
A |
$0.79 |
$300,575 |
I/I |
380,475 |
1,721,273 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-06-30 |
5 |
A |
$0.71 |
$254,191 |
I/I |
358,015 |
1,340,798 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-03-31 |
5 |
A |
$0.44 |
$132,859 |
I/I |
301,952 |
982,783 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-12-31 |
4 |
A |
$0.28 |
$72,808 |
I/I |
260,027 |
680,831 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-09-30 |
4 |
A |
$0.50 |
$106,568 |
I/I |
213,136 |
420,804 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
500,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,500 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
509,426 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
